Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 63Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 44Glioblastoma 42Stomach Neoplasms 37Esophageal Neoplasms 33Brain Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Colorectal Neoplasms 29Pancreatic Neoplasms 26Lung Neoplasms 24Neoplasms 23Glioma 23Astrocytoma 22Neoplasm Metastasis 21Head and Neck Neoplasms 19Sarcoma 18Gliosarcoma 15Esophageal Squamous Cell Carcinoma 15Central Nervous System Neoplasms 15Ovarian Neoplasms 14Oligodendroglioma 13Melanoma 13Colonic Neoplasms 12Carcinoma, Hepatocellular 12Adenocarcinoma Of Esophagus 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Oropharyngeal Neoplasms 9Carcinoma, Ovarian Epithelial 9

Interventions

cemiplimab 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Cisplatin 1Chemoradiotherapy 1Carboplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sinonasal Squamous Cell Carcinoma × Surgical Procedures, Operative × Clear all
NCT07281417 2026-05-22

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 2 Recruiting
108 enrolled

Sinonasal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡